Found: 19
Select item for more details and to access through your institution.
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 1, p. 1, doi. 10.1371/journal.pntd.0007126
- By:
- Publication type:
- Article
Editorial: Ivermectin and COVID-19: Keeping Rigor in Times of Urgency.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2020, v. 102, n. 6, p. 1156, doi. 10.4269/ajtmh.20-0271
- By:
- Publication type:
- Article
Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans.
- Published in:
- PLoS Neglected Tropical Diseases, 2024, v. 18, n. 4, p. 1, doi. 10.1371/journal.pntd.0011867
- By:
- Publication type:
- Article
Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent-authors' response.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent—authors' response.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 59, n. 3, p. 544
- By:
- Publication type:
- Article
Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 57, n. 2, p. 252
- By:
- Publication type:
- Article
Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 4, p. 381, doi. 10.3390/antibiotics10040381
- By:
- Publication type:
- Article
Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment.
- Published in:
- PLoS Neglected Tropical Diseases, 2015, v. 9, n. 8, p. 1, doi. 10.1371/journal.pntd.0003996
- By:
- Publication type:
- Article
In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39647-9
- By:
- Publication type:
- Article
In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39647-9
- By:
- Publication type:
- Article
Challenges faced by multi-displinary new investigators on addressing grand challenges in global health.
- Published in:
- Globalization & Health, 2014, v. 10, n. 1, p. 1, doi. 10.1186/1744-8603-10-27
- By:
- Publication type:
- Article
Challenges faced by multidisplinary new investigators on addressing grand challenges in global health.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 2, p. 335, doi. 10.3390/antibiotics12020335
- By:
- Publication type:
- Article
Evaluation of critical parameters in the hollow‐fibre system for tuberculosis: A case study of moxifloxacin.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 7, p. 1711, doi. 10.1111/bcp.16068
- By:
- Publication type:
- Article
Repurposing clinically approved cephalosporins for tuberculosis therapy.
- Published in:
- Scientific Reports, 2016, p. 34293, doi. 10.1038/srep34293
- By:
- Publication type:
- Article
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 771, doi. 10.3390/ijms23020771
- By:
- Publication type:
- Article